Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9AZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,952
Award facts
- Contract value 100% obligated
- $35,951.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,951.80 to AmerisourceBergen Drug Corp for the supply of Cosentyx Unoready 300 mg pens (2 mL) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price contract with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is the company's headquarters location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for Cosentyx—a biologic medication used in rheumatologic and dermatologic applications—exemplifies the company's role in fulfilling critical medical supply requirements for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9AZR?
SPE2DR26F9AZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9AZR worth?
The government has obligated $35,952 on SPE2DR26F9AZR.
Is contract SPE2DR26F9AZR an order under another contract?
Yes. SPE2DR26F9AZR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AZR competed?
The extent of competition for SPE2DR26F9AZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award